NCT05895318

Brief Summary

The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans diagnosed with PTSD and enrolled for care at the VA understand MDMA-assisted therapy for PTSD? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding MDMA-Assisted Therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

8 months

First QC Date

May 31, 2023

Last Update Submit

June 20, 2023

Conditions

Keywords

MDMAMDMA-Assisted TherapyPsychedelicPTSD

Outcome Measures

Primary Outcomes (3)

  • Patient Health Questionnaire 9

    Screening tool for depressive symptoms. Scores range from 0-27 with lower scores indicating better outcomes

    2 weeks

  • PTSD Checklist for DSM5

    Screening tool for PTSD symptoms. Scores range from 0-80 with lower scores indicating better outcomes

    4 weeks

  • 5 Item Screener for PTSD

    Screening tool for PTSD symptoms. Scores range from 0-4 with lower scores indicating better outcomes.

    2 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The demographic makeup of the sample mimics the demographic makeup of the population of veterans served by VA. As such, the racial distributions will likely be primarily Caucasian, the sample is likely to be predominantly male, ranging in age from 20-100, with an average of 58 years.

You may qualify if:

  • Veterans enrolled in VA care
  • Active diagnosis of PTSD, as determined by the referring provider or confirmed by medical records.
  • Age 18 or older
  • Fluent in written and spoken English

You may not qualify if:

  • Cognitively impaired to the extent that patient cannot comprehend the survey
  • Has already completed the interview

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stratton VA Medical Center

Albany, New York, 12208, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Caitlin Holley, Ph.D.

    Stratton VA Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2023

First Posted

June 8, 2023

Study Start

August 8, 2022

Primary Completion

March 23, 2023

Study Completion

March 23, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations